FDA ends emergency approval for hydroxychloroquine, condemns people to die from coronavirus
Published
(Natural News) In an apparent act of spite against President Donald Trump, the U.S. Food and Drug Administration (FDA) has withdrawn emergency approval for hydroxychloroquine, the generic anti-malaria drug that many doctors have been prescribing to patients with the Wuhan coronavirus (COVID-19). Citing alleged safety and effectiveness concerns, the FDA revoked authorizations for both hydroxychloroquine...
Full Article